IB Acquisition (IBAC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.86, +0.00% vs the prior close of $10.86.
- Volume 120 shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
IBAC ends flat (+0.0%) to $10.86, 18 down days in a row. Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
IBAC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IBAC ends flat (+0.0%) to $10.86, 18 down days in a row
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
- Volume was 120 shares, 0.1x its 50-day average of 1.63K — lighter than usual.
- Price is -0.8% vs its 50-day average ($10.95) and +0.8% vs its 200-day average ($10.78).
- 52-week range $10.19–$11.64; today's close sits at 46% of that range, 6.7% below the 52-week high.
- That makes 18 straight losses.
Oct 15, 2026 — IBAC ends flat (+0.0%) to $10.86, 17 down days in a row
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
- Price is -0.8% vs its 50-day average ($10.95) and +0.8% vs its 200-day average ($10.78).
- 52-week range $10.19–$11.64; today's close sits at 46% of that range, 6.7% below the 52-week high.
- That makes 17 straight losses.
- SEC filings that day: 8-K.
Oct 14, 2026 — IBAC ends flat (+0.0%) to $10.86, 16 down days in a row
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.87, opened at $10.87.
- Volume was 600 shares, 0.4x its 50-day average of 1.66K — lighter than usual.
- Price is -0.8% vs its 50-day average ($10.95) and +0.8% vs its 200-day average ($10.77).
- 52-week range $10.19–$11.64; today's close sits at 46% of that range, 6.7% below the 52-week high.
- That makes 16 straight losses.
Oct 13, 2026 — IBAC ends flat (+0.0%) to $10.86, 15 down days in a row
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
- Price is -0.8% vs its 50-day average ($10.95) and +0.8% vs its 200-day average ($10.77).
- 52-week range $10.19–$11.64; today's close sits at 46% of that range, 6.7% below the 52-week high.
- That makes 15 straight losses.
Oct 12, 2026 — IBAC ends flat (-0.2%) to $10.86, a 1-month low, 14 down days in a row
- Closed at $10.86, -0.18% vs the prior close of $10.88. Day range $10.86–$10.86, opened at $10.86.
- Volume was 700 shares, 0.4x its 50-day average of 1.65K — lighter than usual.
- Price is -0.8% vs its 50-day average ($10.95) and +0.8% vs its 200-day average ($10.77).
- 52-week range $10.19–$11.64; today's close sits at 46% of that range, 6.7% below the 52-week high.
- That makes 14 straight losses.
Oct 9, 2026 — IBAC ends flat (+0.0%) to $10.88, 13 down days in a row
- Closed at $10.88, +0.00% vs the prior close of $10.88. Day range $10.88–$10.88, opened at $10.88.
- Price is -0.6% vs its 50-day average ($10.95) and +1.0% vs its 200-day average ($10.77).
- 52-week range $10.19–$11.64; today's close sits at 48% of that range, 6.5% below the 52-week high.
- That makes 13 straight losses.
Oct 8, 2026 — IBAC ends flat (+0.0%) to $10.88, 12 down days in a row
- Closed at $10.88, +0.00% vs the prior close of $10.88. Day range $10.88–$10.88, opened at $10.88.
- Price is -0.6% vs its 50-day average ($10.95) and +1.1% vs its 200-day average ($10.76).
- 52-week range $10.19–$11.64; today's close sits at 48% of that range, 6.5% below the 52-week high.
- That makes 12 straight losses.
Oct 7, 2026 — IBAC ends flat (+0.0%) to $10.88, 11 down days in a row
- Closed at $10.88, +0.00% vs the prior close of $10.88. Day range $10.88–$10.88, opened at $10.88.
- Volume was 100 shares, 0.1x its 50-day average of 1.75K — lighter than usual.
- Price is -0.6% vs its 50-day average ($10.95) and +1.1% vs its 200-day average ($10.76).
- 52-week range $10.19–$11.64; today's close sits at 48% of that range, 6.5% below the 52-week high.
- That makes 11 straight losses.
Oct 6, 2026 — IBAC ends flat (+0.0%) to $10.88, 10 down days in a row
- Closed at $10.88, +0.00% vs the prior close of $10.88. Day range $10.88–$10.88, opened at $10.88.
- Volume was 2.00K shares, 1.2x its 50-day average of 1.71K.
- Price is -0.6% vs its 50-day average ($10.94) and +1.1% vs its 200-day average ($10.76).
- 52-week range $10.19–$11.64; today's close sits at 48% of that range, 6.5% below the 52-week high.
- That makes 10 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — IBAC ends flat (-0.3%) to $10.88, a 1-month low, 9 down days in a row
- Closed at $10.88, -0.27% vs the prior close of $10.91. Day range $10.88–$10.90, opened at $10.90.
- Volume was 2.90K shares, 1.8x its 50-day average of 1.66K.
- Price is -0.6% vs its 50-day average ($10.94) and +1.1% vs its 200-day average ($10.76).
- 52-week range $10.19–$11.64; today's close sits at 48% of that range, 6.5% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — IBAC ends flat (+0.0%) to $10.91, 8 down days in a row
- Closed at $10.91, +0.00% vs the prior close of $10.91. Day range $10.91–$10.91, opened at $10.91.
- Price is -0.3% vs its 50-day average ($10.94) and +1.4% vs its 200-day average ($10.76).
- 52-week range $10.19–$11.64; today's close sits at 50% of that range, 6.3% below the 52-week high.
- That makes 8 straight losses.
IBAC latest news & SEC filings
Every SEC filing by or about IBAC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.08 — Set shareholder nomination dates.
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Sep 23, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 4, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 25, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$567.17K (prior year $818.61K) (loss widened vs Jun 30, 2025)
Things to know before you trade IBAC
- How much it moves: over the last 20 sessions the average daily move was 0.75% (largest 5.2%). That is a relatively calm stock.
- Liquidity: about 1.82K shares (≈$19.72K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.86 vs a range of $10.19–$11.64 (46% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Arbitrage Llc Aqr sold 6,262 shares on Mar 23, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 6, 2026; 8-K Sep 30, 2026.
- Share count: 5.01M shares outstanding (Aug 14, 2026), -68.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
IBAC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 120 |
| Oct 15, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 0 |
| Oct 14, 2026 | 10.87 | 10.87 | 10.86 | 10.86 | 600 |
| Oct 13, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 0 |
| Oct 12, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 700 |
| Oct 9, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 0 |
| Oct 8, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 0 |
| Oct 7, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 100 |
| Oct 6, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 2.00K |
| Oct 5, 2026 | 10.90 | 10.90 | 10.88 | 10.88 | 2.90K |
| Oct 2, 2026 | 10.91 | 10.91 | 10.91 | 10.91 | 0 |
| Oct 1, 2026 | 10.91 | 10.91 | 10.91 | 10.91 | 700 |
| Sep 30, 2026 | 10.95 | 11.12 | 10.90 | 10.91 | 15.60K |
| Sep 29, 2026 | 11.11 | 11.38 | 11.10 | 11.10 | 1.60K |
| Sep 28, 2026 | 11.30 | 11.30 | 11.30 | 11.30 | 0 |
| Sep 25, 2026 | 11.30 | 11.30 | 11.30 | 11.30 | 0 |
| Sep 24, 2026 | 11.40 | 11.52 | 11.30 | 11.30 | 3.20K |
| Sep 23, 2026 | 11.40 | 11.42 | 11.40 | 11.40 | 2.10K |
| Sep 22, 2026 | 11.30 | 11.50 | 11.30 | 11.50 | 1.50K |
| Sep 21, 2026 | 11.20 | 11.20 | 10.96 | 11.04 | 5.20K |
About IB Acquisition
IB Acquisition (IBAC) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in BOCA RATON, FL. State of incorporation: NV. Fiscal year ends September 30. SEC CIK 1998781.
IBAC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 6,262 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 40,144 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 56,145 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,623 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 25,087 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 138,005 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 29,888 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,059 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 26,410 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 10,377 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 6,262 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 40,144 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 56,145 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,623 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 25,087 | $10.80 |
IBAC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $3.42M | — | $-1.32M |
| Sep 30, 2024 | — | $1.87M | — | $-820.96K |
| Sep 30, 2023 | — | $-6.84K | — | $-207 |
Latest balance sheet: total assets $8.52M, total liabilities $2.45M, cash $30.16K (as of Jun 30, 2026).
IBAC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Medpace (MEDP)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IBAC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.